NEW YORK REGIONAL CENTER FOR DIABETES TRANSLATION RESEARCH PILOT AND FEASIBILITY PROGRAM FUNDING ANNOUNCEMENT: 2022
The New York Regional Center for Diabetes Translation Research (NY-CDTR) announces the availability of Pilot and Feasibility (P&F) funding for preliminary studies to support planned extramural funding applications (NIH preferred) for diabetes-related translational research.
Budget requests can be up to $50,000/year for one-year, or up to $25,000/year for 2 years. Meritorious proposals for $50,000/year for 2 years will also be considered, with a maximum of one such award being granted. A 2nd year of funding is always contingent on progress and available program funding.
Proposals should use translational research methods such as: implementation or dissemination science, natural experiment methods, as well as quantitative or qualitative methods. Community and other stakeholder engagement is desirable. Secondary analyses of pertinent data sets are also welcome.
Applications involving research in diabetes/obesity across the life span, population health and health systems, or behavioral science and technology are encouraged. Translation research focused on Latinos and social determinants of health is of particular interest. All proposals are expected to address health equity. P&F funds may supplement ongoing funded research projects (e.g., K-awards), but non-overlap must be clearly demonstrated in the proposal. The NY-CDTR website (www.nycdtr.org) provides information on core resources and services available to awardees to support their pilot studies.
The CDTR website www.nycdtr.org provides information re: core resources and services available to awardees to support their pilot study.
ELIGIBILITY: Must hold a faculty appointment at the time of award (postdoctoral fellows are not eligible). This program is designed to support (in order of priority):
APPLICATION PROCESS. Letters of Intent consisting of a one-paragraph overview of your primary research question and study design are strongly encouraged and should be emailed to the program directors by April 11th, 2022. Consultations from the directors and NY-CDTR Core Faculty are available to you as you develop your application (Email us!). Full applications should be emailed to the program directors by May 16th, 2022 and must: 1) clearly delineate the rationale and aims of the research; 2) describe rigorous study procedures; 3) include sample size justification and a data analysis plan; 4) describe use of NY-CDTR Core resources; and 5) discuss how the proposed research will support a future application for external funding (NIH preferred). In-kind ongoing consultation and mentorship are available to awardees. Pilot funding may be used to support PI effort at a minimal level (<10%). INDIRECT COSTS ARE NOT ALLOWED.
No internal grant forms or approval signatures are needed to submit an application. However, IRB approval is needed for protection of human subjects if the proposal is selected for funding. Required application components are detailed in #9 on the following FAQ page. You are encouraged to identify appropriate reviewers and submit their names and email addresses with your application. Submit the application components as a single Word or PDF document. Please use relevant NIH PHS 398 grant application forms, which can be downloaded from the NIH website: http://grants.nih.gov/grants/funding/phs398/phs398.html.
Provide these components as a single Word or PDF document. If PDF format is used, also include a copy of the abstract as a Word document. Please use selected NIH PHS 398 grant application forms, which can be downloaded from the NIH website: http://grants.nih.gov/grants/funding/phs398/phs398.html.
Email the P&F Program Directors: Dr. Judith Wylie-Rosett (judith.wylie-rosett@einsteinmed.edu) and Dr. Shivani Agarwal (shivani.agarwal@einsteinmed.edu).
Earliest start date for successful applications: September 1, 2022.
Frequently Asked Questions